Ivacaftor/Lumacaftor | m-entrepreneurship.com

Product Name :
Ivacaftor/Lumacaftor

Search keywords :
Doxorubicin

drugId :
null

Target Vo:
Cystic fibrosis transmembrane conductance regulator

Target Vo Short Name :
CFTR

Moa_Name:
P-glycoprotein 1 inhibitors

First Approval Country :
United States

First Approval Date Filter:
2015

Origin Company_Name :
Vertex Pharmaceuticals Incorporated

Active Company_Name :
Vertex Pharmaceuticals Incorporated

Active Indication_Name:
Cystic Fibrosis

In Active Indication_Name:

Termination Status :

China Termination Status :

Highest Status:
Approved

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
TSG101 Rabbit mAb Epigenetic Reader Domain
Hsp90 alpha Rabbit mAb Epigenetics
Arginase-1 Antibody: Arginase-1 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 35 kDa, targeting to Arginase-1. It can be used for WB,IHC-P assays with tag free, in the background of Human.

Author: Betaine hydrochloride

Related Posts